Best EORs for Biotech Companies in Mexico (2026)

Biotech companies expanding into Mexico are hiring a specific type of professional: Medical Science Liaisons, Regulatory Affairs Specialists, Clinical Research Associates, Pharmacovigilance Managers, and Quality Assurance leads.

These are not entry-level roles. They require bilingual fluency, deep domain expertise, and in many cases access to confidential clinical trial data, regulatory submissions, and proprietary research.

The employment structure that surrounds them must reflect that.

For a biotech company without a Mexican legal entity, an Employer of Record is the fastest and most compliant path to putting these professionals on payroll in Mexico.

But not every EOR is equipped to handle the specific compliance demands of scientific and regulatory roles at senior compensation levels.

This guide evaluates the best EOR providers for biotech companies hiring in Mexico in 2026.

What biotech companies need from a Mexico EOR

Biotech hires in Mexico are senior, domain-specific roles with access to confidential data. The EOR structure surrounding them must reflect that.

Here is what to require from any provider before signing:

• IP assignment in the contract. LFT Article 163 assigns inventions to the employer only when the employment relationship is properly documented. The IP assignment clause must be explicit, bilingual, and in place before the employee's first day.
  
  

• NDA provisions from day one. Clinical trial protocols, pharmacovigilance data, and regulatory submissions require enforceable confidentiality clauses scoped specifically for Mexico's labor courts.
  
  

• 180-day probation applied. For senior scientific and specialist roles, LFT Article 39-A allows 180 days. Generic platforms apply 30 days by default. This protection is lost if the EOR does not actively apply it.
  
  

• SBC cap modeling at senior salary levels. MSLs and Regulatory Affairs Specialists typically earn MXN 60,000–120,000/month. The IMSS cap at 25 UMA/day reduces the effective employer burden to 20–27% at this range, not the flat 30–40% most EORs quote.
  
  

• NOM-035 managed as standard. Clinical and regulatory roles involve high-workload environments. NOM-035 psychosocial risk assessments are mandatory annually. NOM-037 applies for remote employees. Neither is optional.
  
  

• Active REPSE registration. Required under the 2021 outsourcing reform. Without it, the arrangement may be classified as illegal subcontracting and joint liability falls on your company.
  
  

• Owned Mexican entity. EORs routing employment through undisclosed local partners add legal uncertainty to the IP ownership chain. For biotech, this is not an acceptable structure.
  
  

The best EOR providers for biotech companies in Mexico (2026)

1. Human Resources Mexico (HRM): best for senior biotech professional hiring

Human Resources Mexico (HRM) is a Mexico-only Employer of Record with 17 years of physical presence in Mexico.

For biotech companies, our specialization in high-compensation professional profiles is directly relevant.

Our minimum engagement salary of MXN 550,000 gross per year corresponds precisely to the senior scientific and regulatory profiles that biotech companies need to place in Mexico.

Why we lead for biotech hires:

• IP and NDA provisions built into every contract: LFT Article 163-compliant IP assignment and bilingual NDA clauses are standard in our employment contracts, not optional add-ons
  
  

• Extended probation applied as standard: We apply the 180-day probation period to senior and specialist roles, protecting your investment in high-stakes scientific hires
  
  

• REPSE registration: Active and publicly verifiable on the STPS portal
  
  

• Third-party compliance audit: Independent verification of our IMSS, ISR, CFDI, and LFT compliance
  
  

• NOM-035 and NOM-037 managed operationally: Our HR team manages psychosocial risk assessments and remote work compliance as standard obligations, not project-based extras
  
  

• SBC cap modeling at senior salary levels: We correctly model employer costs at MXN 60,000–120,000/month ranges, where the IMSS cap creates a meaningful reduction in effective burden rate
  
  

• 100% human support: No AI chatbots for clients or employees: every inquiry handled by a bilingual HR professional physically based in Mexico
  
  

• PTU paid by us: Our mandated profit-sharing obligation is not billed back to clients
  
  

• No security deposits, no setup fees, no termination fees
  
  

• 17 years of physical presence in Mexico: Our entity, our team, our IMSS and SAT registrations
  
  

Pricing: Single percentage markup on gross taxable salary. Tax-deductible benefits (medical insurance, gas cards, food coupons, IAVE cards) excluded from the fee base.

Best for: US, EU, and Australian biotech companies hiring Medical Science Liaisons, Regulatory Affairs Specialists, Clinical Research Associates, Pharmacovigilance leads, and Medical Affairs professionals in Mexico.

2. Globalization Partners (G-P): enterprise biotech with multi-country needs

G-P has a registered legal entity in Mexico and holds REPSE registration.

For large biotech and pharma enterprises already using G-P's platform across multiple Latin American or global markets, adding Mexico hiring to an existing deployment is operationally straightforward.

G-P's Workday, SuccessFactors, and SAP integrations are a practical advantage for large biotech organizations with existing HCM infrastructure.

The limitation for biotech specifically: G-P's Mexico presence is a fiscal entity without a physical office or dedicated in-country HR staff.

For senior scientific roles where employment questions, NDA clarifications, or compliance concerns arise, support is managed remotely through centralized global teams rather than by specialists physically based in Mexico.

Pricing: Quote-required. Not published publicly.

3. Prodensa: established Mexican operator for industrial biotech and pharma manufacturing

Prodensa is a REPSE-registered Mexican EOR headquartered in Monterrey with 39 years of continuous operation. It holds its own Mexican entity and maintains nationwide offices.

For biotech and pharmaceutical companies with manufacturing, quality control, or laboratory operations in Mexico's industrial corridor (Monterrey, Saltillo, San Luis Potosí), Prodensa's depth is relevant.

Its service model is oriented toward large-scale enterprise and manufacturing operations.

For a clinical-stage biotech hiring a Medical Science Liaison in Mexico City or a remote Regulatory Affairs Specialist, Prodensa is not the natural fit.

4. Deel: multi-country biotech hiring

Deel covers 150+ countries with a flat EOR fee of $599/month per employee.

For biotech companies simultaneously hiring in Mexico, Brazil, Colombia, and European markets from a single platform, Deel's consolidation is a convenience.

Deel does not own a legal entity in Mexico and does not hold active REPSE registration. It operates through a fiscal address and third-party partners.

For biotech companies with IP protection requirements, the absence of a direct Mexican entity adds uncertainty about who is actually the registered employer and who is responsible for the employment documentation.

5. Remote: global platform with IP focus

Remote covers 190+ countries and positions its IP protection documentation as a differentiator for technology and scientific companies.

Remote does not own a legal entity in Mexico and does not hold active REPSE registration. It operates through third-party in-country partners.

The employment relationship for your Mexico-based Medical Science Liaison or Regulatory Affairs Specialist runs through an entity you have not evaluated and cannot verify.

Remote's flat fee of 599/month(699 month-to-month) creates a cost advantage for very high-salary biotech executives compared to percentage-based pricing models.

Entity ownership and REPSE: the biotech compliance matrix

For biotech companies specifically, IP protection and data confidentiality make direct entity ownership more important than for most other verticals.

The legal ownership chain for research outputs, regulatory submissions, and clinical data must be clear and unambiguous.

Key biotech roles and Mexico salary benchmarks (2026)

Understanding market compensation helps you evaluate EOR cost models accurately.

Exchange rate: MXN 18 per USD (2026 Banxico reference rate)

At MXN 80,000–120,000/month, the IMSS contribution cap applies. The effective employer burden rate at these salary levels drops to approximately 20–27%, compared to the 35% that applies at MXN 50,000/month.

Providers who model this correctly give you a meaningfully different, more accurate cost picture.

Use our Mexico ISR Calculator to model net take-home pay and total employer cost at any biotech salary level before making an offer.

Hiring your Mexico biotech team compliantly

Human Resources Mexico (HRM) is Mexico's most experienced Employer of Record for senior professional hiring. We are the legal employer for every professional hired on your behalf. IP assignment clauses, NDA provisions, extended probation, REPSE registration, and CFDI 4.0 payroll are all in place from day one.

For biotech companies placing Medical Science Liaisons, Regulatory Affairs Specialists, or clinical operations professionals in Mexico, the employment structure matters as much as the hire itself.

Get a custom proposal with full SBC cap modeling at your specific biotech salary levels.

Have questions about NDA enforceability, IP assignment, or employment structure for scientific roles in Mexico? Ask our Mexico EOR Specialist AI Chatbot for immediate answers.

Frequently asked questions

What is the best EOR for biotech companies hiring in Mexico?

Human Resources Mexico (HRM) is the best EOR for biotech companies hiring in Mexico.

We own our Mexican entity, hold REPSE registration, include IP and NDA clauses in every contract, and specialize in senior professional profiles at MXN 550,000+ gross per year.

Does IP protection require a specific employment structure in Mexico?

Yes. LFT Article 163 assigns inventions made during formal employment to the employer, but only when the employment relationship is properly documented.

The IP assignment must be explicitly included in the employment contract from day one. A generic EOR contract without this clause creates an IP ownership gap.

What biotech roles are most commonly hired through an EOR in Mexico?

The most active biotech hiring categories in Mexico are Medical Science Liaisons, Regulatory Affairs Specialists, Clinical Research Associates, Pharmacovigilance Specialists, Medical Affairs Managers, and Quality Assurance Managers.

How does the IMSS cap affect biotech hiring costs?

At MXN 89,156/month equivalent (25 UMA/day at 2026 values), IMSS and INFONAVIT contributions stop increasing proportionally.

Biotech professionals earning MXN 80,000–120,000/month generate an effective employer burden of approximately 20–27%, not the 35% that applies at lower salary levels.

Does NOM-035 apply to biotech employees in Mexico?

Yes. NOM-035 (psychosocial risk factors) applies to all Mexican employers regardless of industry. For clinical and regulatory roles with demanding workloads, NOM-035 assessments are a mandatory employer obligation.

NOM-037 also applies for remote employees. Both must be managed as operational standards, not optional.

What is REPSE and why does it matter for biotech companies?

REPSE is Mexico's federal registry for specialized employment service providers, required under the 2021 outsourcing reform. Any EOR your biotech company uses in Mexico must hold active REPSE registration.

Without it, the arrangement may be classified as illegal subcontracting, with joint liability falling on your company for unpaid IMSS and SAT obligations.

Data Source: Information on legal entities and company registrations in this article is based on data available through Dun & Bradstreet (D&B). If a legal entity is not listed in D&B's business records, we have not identified it as a separately listed legal entity for the purposes of this comparison.

Note: D&B provides business intelligence and company identity data, which we use as the source for the legal-entity information presented in this article.